Inside informationEnglish
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 10/07/2026, 14:34
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112222_20260710
Filed the same day
- Sanofi: Information concerning the total number of voting rights and shares - June 2026Voting rights and capital
- Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin 2026Voting rights and capitalFrench